tradingkey.logo

Arcadia Biosciences Inc

RKDA
3.040USD
-0.170-5.30%
收盤 12/24, 13:00美東報價延遲15分鐘
4.16M總市值
虧損本益比TTM

Arcadia Biosciences Inc

3.040
-0.170-5.30%

關於 Arcadia Biosciences Inc 公司

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Arcadia Biosciences Inc簡介

公司代碼RKDA
公司名稱Arcadia Biosciences Inc
上市日期May 15, 2015
CEOSchaefer (Thomas J)
員工數量9
證券類型Ordinary Share
年結日May 15
公司地址5956 Sherry Lane
城市DALLAS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75225
電話12149748921
網址https://arcadiabio.com/
公司代碼RKDA
上市日期May 15, 2015
CEOSchaefer (Thomas J)

Arcadia Biosciences Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Deborah D. (Debbie) Carosella
Ms. Deborah D. (Debbie) Carosella
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
其他
95.52%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
其他
95.52%
股東類型
持股股東
佔比
Investment Advisor
2.73%
Investment Advisor/Hedge Fund
1.83%
Individual Investor
0.82%
Hedge Fund
0.12%
Research Firm
0.08%
其他
94.42%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
30
58.96K
4.31%
-249.34K
2025Q2
35
87.93K
6.43%
-234.13K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
2023Q2
66
255.84K
27.41%
-81.95K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
14.04K
1.03%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
12.79K
0.94%
--
--
Jun 30, 2025
Mariner Wealth Advisors
14.50K
1.06%
-12.98K
-47.24%
Jun 30, 2025
State Street Investment Management (US)
12.15K
0.89%
--
--
Jun 30, 2025
Jacot (Stanley Jr)
5.00K
0.37%
--
--
Mar 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Mar 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Mar 31, 2025
Tower Research Capital LLC
1.92K
0.14%
+1.48K
+338.22%
Jun 30, 2025
UBS Financial Services, Inc.
2.51K
0.18%
-6.02K
-70.57%
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
公告日期
類型
比率
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1

常見問題

Arcadia Biosciences Inc的前五大股東是誰?

Arcadia Biosciences Inc的前五大股東如下:
The Vanguard Group, Inc.
持有股份:14.04K
佔總股份比例:1.03%。
Geode Capital Management, L.L.C.
持有股份:12.79K
佔總股份比例:0.94%。
Mariner Wealth Advisors
持有股份:14.50K
佔總股份比例:1.06%。
State Street Investment Management (US)
持有股份:12.15K
佔總股份比例:0.89%。
Jacot (Stanley Jr)
持有股份:5.00K
佔總股份比例:0.37%。

Arcadia Biosciences Inc的前三大股東類型是什麼?

Arcadia Biosciences Inc 的前三大股東類型分別是:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Mariner Wealth Advisors

有多少機構持有Arcadia Biosciences Inc(RKDA)的股份?

截至2025Q3,共有30家機構持有Arcadia Biosciences Inc的股份,合計持有的股份價值約為58.96K,占公司總股份的4.31% 。與2025Q2相比,機構持股有所增加,增幅為-2.12%。

哪個業務部門對Arcadia Biosciences Inc的收入貢獻最大?

在FY2024,--業務部門對Arcadia Biosciences Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI